Tarsus Pharmaceuticals is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics. The company’s pipeline products include TP-03, TP-04 and ...

Jan. 13, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today provided an update on the Company’s key priorities for 2025, including plans to advance TP-04 for the potential ...

Tarsus Pharmaceuticals, Inc. has announced plans to advance TP-04, an investigational ophthalmic gel formulation of lotilaner, for the treatment of Ocular Rosacea, a significant but currently ...

Jan. 13, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today provided an update on the Company’s key priorities for 2025, including plans to advance TP-04 for the ...

Tarsus, located in the Cilicia region of southern Anatolia (modern-day Turkey), was an ancient city of great cultural and historical significance. Settlements in Tarsus date back to the Neolithic ...

Nearly a century of innovation and vision: that’s what it takes to be the University of Oklahoma. And it’s what makes the University of Oklahoma's Michael F. Price College of Business #1 in Oklahoma, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...